Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Green Cap Health vs Rylo Health

Green Cap Health
Graded #258

Lower grade

vs+1.5
Rylo Health
Graded #236

Higher grade

The verdict

Rylo Health takes it — 64.7/100 to 63.2/100, but only just.

Rylo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Texas-prescriber telehealth selling compounded semaglutide and tirzepatide alongside a peptide line, naming both its medical group and its dispensing pharmacy. Green Cap Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGreen Cap Health +10
74
64
Dose & formulationEven
64
64
Clinical oversightRylo Health +7
68
75
Labs & monitoringRylo Health +1
52
53
FulfillmentRylo Health +27
56
83
Contract termsGreen Cap Health +10
47
37
Green Cap Health · left barRylo Health · right bar

The numbers

MetricGreen Cap HealthRylo Health
WeighScore63.2/10064.7/100
GradeCC
Scorecard rank#258#236
Semaglutide$129/mo (6-month plan, compounded)$149/mo (promotional rate, compounded)
Tirzepatide$199/mo (6-month plan, compounded)$249/mo (compounded)
Coverage1 stateAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Green Cap Health

Graded #258 · C

Strengths

  • Vertically integrated: the prescribing practice and the compounding pharmacy are the same company, so the supply chain is short and named
  • Same-day provider review and 1-3 day discreet shipping
  • The full commitment ladder is published, so the month-to-month rate and the six-month rate can be compared directly

Where it loses points

  • The advertised $2.63-a-day and $79 first-month figures do not correspond to any purchasable plan; the cheapest real rates are $129/mo semaglutide and $199/mo tirzepatide, both on six-month commitments, and month-to-month is $179 and $279
  • The terms disclose a separate Weight Management Program Membership Fee, charged periodically on top of the plan and revealed only during checkout — it appears on no product page
  • The terms also state recurring fees are charged in advance without seeking any additional authorisation
  • Service is Texas-only, so nothing here is available to a reader outside that state
  • The site's terms link out to lifemd.com's terms — the legal text is another company's
Rylo Health

Graded #236 · C

Strengths

  • Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
  • Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
  • Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
  • Cancel in one click from the patient portal, with no contracts and no cancellation fees
  • Peptide line priced openly, including NAD+ and sermorelin

Where it loses points

  • Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
  • No LegitScript certification is claimed or displayed
  • Several peptide products are advertised as coming soon rather than available
  • No published refund policy beyond the no-cancellation-fee statement

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard